尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Murphy Peter C., Directeur Commercial. Director active across 1 company, notably TELA Bio, Inc.. Aggregated, 7 filings have been published. Activity tracked since 23 February 2022. The latest transaction was disclosed on 31 March 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Murphy Peter C. is Directeur Commercial and Chief Commercial Officer at TELA Bio, Inc. He has 7 filings in total, and across the 7 sampled filings between 2022-02-25 and 2024-04-02, the modal transaction nature is Retenue fiscale, with individual amounts up to EUR 9950.04766874064.